Literature DB >> 15021207

Update on attention-deficit/hyperactivity disorder.

Katie Campbell Daley1.   

Abstract

PURPOSE OF REVIEW: Attention-deficit/hyperactivity disorder (ADHD) is present in 3% to 10% of children in the United States. Children with ADHD can have academic impairments, social dysfunction, and poor self-esteem. There is also a higher risk of both cigarette smoking and substance abuse. Given this, the importance of treatment for ADHD needs to be underscored. This article will briefly review the diagnosis, etiology, and treatment of ADHD, with particular focus on nonstimulant medication and alternative treatment modalities. RECENT
FINDINGS: Recent evidence suggests that the overall rate of medication treatment for ADHD has been increasing, with over 2 million children being treated with stimulants in 1997. With this increase, controversy has arisen over the possible association of stimulants with growth suppression. In addition, estimates indicate that as many as 30% of children with ADHD either do not respond to stimulant treatment or cannot tolerate the treatment secondary to side effects. This has lead to the consideration of treatment with both nonstimulant medications as well as alternative therapies, including diet, iron supplementation, herbal medications, and neurofeedback. Considering the various treatment options now available for ADHD, along with the complexity of the condition, clinical practice guidelines are emerging for the treatment of ADHD and will be discussed.
SUMMARY: ADHD continues to be a serious health problem. Adequate treatment is needed to avoid academic impairments, social dysfunction, and poor self-esteem. This treatment includes consideration of stimulant medication, nonstimulant medication, as well as alternative therapies. The child with ADHD is likely better served with a mutimodal treatment plan, including medication, parent/school counseling, and behavioral therapy. Implementing an evidenced based algorithm for the treatment of ADHD may prove to be most effective.

Entities:  

Mesh:

Year:  2004        PMID: 15021207     DOI: 10.1097/00008480-200404000-00020

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  10 in total

1.  A new rating scale for adult ADHD based on the Symptom Checklist 90 (SCL-90-R).

Authors:  Dominique Eich; Jules Angst; Anja Frei; Vladeta Ajdacic-Gross; Wulf Rössler; Alex Gamma
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-01-03       Impact factor: 5.270

Review 2.  Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.

Authors:  Howard Schubiner
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 3.  Managing attention deficit/hyperactivity disorder: unmet needs and future directions.

Authors:  C R Steer
Journal:  Arch Dis Child       Date:  2005-02       Impact factor: 3.791

4.  Treatment for ADHD: is more complex treatment cost-effective for more complex cases?

Authors:  E Michael Foster; Peter S Jensen; Michael Schlander; William E Pelham; Lily Hechtman; L Eugene Arnold; James M Swanson; Timothy Wigal
Journal:  Health Serv Res       Date:  2007-02       Impact factor: 3.402

Review 5.  Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.

Authors:  Donna Gillies; John Kh Sinn; Sagar S Lad; Matthew J Leach; Melissa J Ross
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

6.  Impact of methylphenidate formulation on treatment patterns and hospitalizations: a retrospective analysis.

Authors:  Jason E Kemner; Maureen J Lage
Journal:  Ann Gen Psychiatry       Date:  2006-04-10       Impact factor: 3.455

7.  Integration of an EEG biomarker with a clinician's ADHD evaluation.

Authors:  Steven M Snyder; Thomas A Rugino; Mady Hornig; Mark A Stein
Journal:  Brain Behav       Date:  2015-03-05       Impact factor: 2.708

8.  Attention-deficit/hyperactivity disorder Under Treatment Outcomes Research (AUTOR): a European observational study in pediatric subjects.

Authors:  Virginia Haynes; Pedro Lopez-Romero; Ernie Anand
Journal:  Atten Defic Hyperact Disord       Date:  2015-06-27

9.  A Randomized Trial of Comparing the Efficacy of Two Neurofeedback Protocols for Treatment of Clinical and Cognitive Symptoms of ADHD: Theta Suppression/Beta Enhancement and Theta Suppression/Alpha Enhancement.

Authors:  Arash Mohagheghi; Shahrokh Amiri; Nafiseh Moghaddasi Bonab; Gholamreza Chalabianloo; Seyed Gholamreza Noorazar; Seyed Mahmoud Tabatabaei; Sara Farhang
Journal:  Biomed Res Int       Date:  2017-02-09       Impact factor: 3.411

10.  Self-reported efficacy of neurofeedback treatment in a clinical randomized controlled study of ADHD children and adolescents.

Authors:  Nezla S Duric; Jörg Aßmus; Irene B Elgen
Journal:  Neuropsychiatr Dis Treat       Date:  2014-09-02       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.